EUVIMEDEUVIMED entdecken
Crossref

A transcriptomic biomarker predictive of cell proliferation for use in adverse outcome pathway-informed testing and assessment

J Christopher Corton iD, Victoria Ledbetter, Samuel M Cohen iD, Ella Atlas iD, Carole L Yauk iD, Jie Liu

Toxicological Sciences · 2024

DOI: 10.1093/toxsci/kfae102 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Toxicological Sciences, 2024. Verfasst von J Christopher Corton und 5 weiteren Autor:innen. Beteiligte Einrichtung: Center for Computational Toxicology and Exposure, US Environmental Protection Agency, Research Triangle Park, NC 27711, United States. Hauptthemen laut MEDLINE: Cell Proliferation, Transcriptome. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 101 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

High-throughput transcriptomics (HTTr) is increasingly being used to identify molecular targets of chemicals that can be linked to adverse outcomes. Cell proliferation (CP) is an important key event in chemical carcinogenesis. Here, we describe the construction and characterization of a gene expression biomarker that is predictive of the CP status in human and rodent tissues. The biomarker was constructed from 30 genes known to be increased in expression in prostate cancers relative to surrounding tissues and in cycling human MCF-7 cells after estrogen receptor (ER) agonist exposure. Using a large compendium of gene expression profiles to test utility, the biomarker could identify increases in CP in (i) 308 out of 367 tumor vs. normal surrounding tissue comparisons from 6 human organs, (ii) MCF-7 cells after activation of ER, (iii) after partial hepatectomy in mice and rats, and (iv) the livers of mice and rats after exposure to nongenotoxic hepatocarcinogens. The biomarker identified suppression of CP (i) under conditions of p53 activation by DNA damaging agents in human cells, (ii) in human A549 lung cells exposed to therapeutic anticancer kinase inhibitors (dasatinib, nilotnib), and (iii) in the mouse liver when comparing high levels of CP at birth to the low background levels in the adult. The responses using the biomarker were similar to those observed using conventional markers of CP including PCNA, Ki67, and BrdU labeling. The CP biomarker will be a useful tool for interpretation of HTTr data streams to identify CP status after exposure to chemicals in human cells or in rodent tissues.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cell ProliferationTranscriptomeHumansAnimalsMiceAdverse Outcome PathwaysRatsMCF-7 CellsMaleFemaleGene Expression ProfilingBiomarkers

Stichwörter der Autor:innen

DNA damagecell proliferationestrogen receptor αgene expression biomarkersgene expression compendiumhepatocarcinogens

Substanzen

Biomarkers

Autor:innen und Institutionen

  • Center for Computational Toxicology and Exposure, US Environmental Protection Agency, Research Triangle Park, NC 27711, United States.
  • Department of Pathology and Microbiology and Buffett Cancer Center, University of Nebraska Medical Center, Omaha, NE 69198-3135, United States.
  • Environmental Health Science and Research Bureau, Healthy Environments and Consumer Safety Branch (HECSB) Health Canada, Ottawa, ON K2K 0K9, Canada.
  • Department of Biology, University of Ottawa, Ottawa, ON, Canada.

ORCID-Profile: J Christopher Corton, Samuel M Cohen, Ella Atlas, Carole L Yauk

Zitieren

APA

Corton, J. C., Ledbetter, V., Cohen, S. M., Atlas, E., Yauk, C. L., & Liu, J. (2024). A transcriptomic biomarker predictive of cell proliferation for use in adverse outcome pathway-informed testing and assessment. Toxicological Sciences. https://doi.org/10.1093/toxsci/kfae102

Vancouver

Corton JC, Ledbetter V, Cohen SM, Atlas E, Yauk CL, Liu J. A transcriptomic biomarker predictive of cell proliferation for use in adverse outcome pathway-informed testing and assessment. Toxicological Sciences. 2024. doi:10.1093/toxsci/kfae102

BibTeX
@article{Corton2024,
  author = {Corton, J Christopher and Ledbetter, Victoria and Cohen, Samuel M and Atlas, Ella and Yauk, Carole L and Liu, Jie},
  title = {A transcriptomic biomarker predictive of cell proliferation for use in adverse outcome pathway-informed testing and assessment},
  journal = {Toxicological Sciences},
  year = {2024},
  doi = {10.1093/toxsci/kfae102}
}
Kostenlos starten →